Yancheng Donggang Pharmaceutical Development Co., Ltd., commonly referred to as Donggang Pharma, is a prominent player in the pharmaceutical industry, headquartered in Yancheng, Jiangsu Province, China. Established in 2001, the company has made significant strides in drug development and manufacturing, focusing on active pharmaceutical ingredients (APIs) and intermediates. With a strong presence in both domestic and international markets, Donggang Pharma is renowned for its commitment to quality and innovation. The company’s core offerings include a diverse range of APIs, which are distinguished by their high purity and compliance with global regulatory standards. Over the years, Donggang Pharma has achieved notable milestones, solidifying its position as a trusted partner in the pharmaceutical supply chain.
How does Yancheng Donggang Pharmaceutical Development Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Yancheng Donggang Pharmaceutical Development Co., Ltd.'s score of 10 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Yancheng Donggang Pharmaceutical Development Co., Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Yancheng Donggang Pharmaceutical Development Co., Ltd. aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the pharmaceutical sector, where companies are increasingly being urged to disclose their environmental impact and set ambitious targets for carbon reduction. In summary, without available emissions data or climate commitments, Yancheng Donggang Pharmaceutical Development Co., Ltd. currently lacks transparency regarding its carbon footprint and climate strategy.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Yancheng Donggang Pharmaceutical Development Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.